Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1.

Nutrients · 2023 · PMC10097176 · PMID 37049472

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Thus, the observed association between the cyclin B1 dependent decreased proliferation and decreased cell cycle progression may suggest that cyclin B1 may be a potential target and/or biomarker that may be significant in AI resistance.

also in 3,256 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.